Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination

Hepatitis A virus (HAV) is one of the well-known viruses that cause hepatitis all around the globe. Although this illness has decreased in developed countries due to extensive immunization, numerous developing and under-developed countries are struggling with this virus. HAV infection can be spread...

Full description

Bibliographic Details
Main Authors: Omid Gholizadeh, Sama Akbarzadeh, Mohamad Ghazanfari Hashemi, Marjan Gholami, Parya Amini, Zahra Yekanipour, Raheleh Tabatabaie, Saman Yasamineh, Parastoo Hosseini, Vahdat Poortahmasebi
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2023/4263309
_version_ 1826993065590521856
author Omid Gholizadeh
Sama Akbarzadeh
Mohamad Ghazanfari Hashemi
Marjan Gholami
Parya Amini
Zahra Yekanipour
Raheleh Tabatabaie
Saman Yasamineh
Parastoo Hosseini
Vahdat Poortahmasebi
author_facet Omid Gholizadeh
Sama Akbarzadeh
Mohamad Ghazanfari Hashemi
Marjan Gholami
Parya Amini
Zahra Yekanipour
Raheleh Tabatabaie
Saman Yasamineh
Parastoo Hosseini
Vahdat Poortahmasebi
author_sort Omid Gholizadeh
collection DOAJ
description Hepatitis A virus (HAV) is one of the well-known viruses that cause hepatitis all around the globe. Although this illness has decreased in developed countries due to extensive immunization, numerous developing and under-developed countries are struggling with this virus. HAV infection can be spread by oral-fecal contact, and there are frequent epidemics through nutrition. Improvements in socioeconomic and sanitary circumstances have caused a shift in the disease’s prevalence worldwide. Younger children are usually asymptomatic, but as they become older, the infection symptoms begin to appear. Symptoms range from slight inflammation and jaundice to acute liver failure in older individuals. While an acute infection may be self-limiting, unrecognized persistent infections, and the misapplication of therapeutic methods based on clinical guidelines are linked to a higher incidence of cirrhosis, hepatocellular carcinoma, and mortality. Fortunately, most patients recover within two months of infection, though 10–15% of patients will relapse within the first six months. A virus seldom leads to persistent infection or liver damage. The mainstay of therapy is based on supportive care. All children from 12–23 months, as well as some susceptible populations, should receive routine vaccinations, according to the Centers for Disease Control and Prevention and the American Academy of Pediatrics. Laboratory diagnosis of HAV is based on antigen detection, checking liver enzyme levels, and antibody screening. Furthermore, polymerase chain reaction (PCR) technology has identified HAV in suspected nutrition sources; therefore, this technique is used for preventative measures and food-related laws.
first_indexed 2024-04-10T22:43:19Z
format Article
id doaj.art-d4977ead46cf4d7a8ada8391290f6cdd
institution Directory Open Access Journal
issn 1918-1493
language English
last_indexed 2025-02-18T08:58:13Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj.art-d4977ead46cf4d7a8ada8391290f6cdd2024-11-02T23:54:01ZengHindawi LimitedCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932023-01-01202310.1155/2023/4263309Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and VaccinationOmid Gholizadeh0Sama Akbarzadeh1Mohamad Ghazanfari Hashemi2Marjan Gholami3Parya Amini4Zahra Yekanipour5Raheleh Tabatabaie6Saman Yasamineh7Parastoo Hosseini8Vahdat Poortahmasebi9Department of Bacteriology and VirologyDepartment of Animal BiologyDepartment of RadiologyDepartment of PharmacyDepartment of MicrobiologyInfectious and Tropical Diseases Research CenterDepartment of ImmunologyInfectious and Tropical Diseases Research CenterDepartment of VirologyDepartment of Bacteriology and VirologyHepatitis A virus (HAV) is one of the well-known viruses that cause hepatitis all around the globe. Although this illness has decreased in developed countries due to extensive immunization, numerous developing and under-developed countries are struggling with this virus. HAV infection can be spread by oral-fecal contact, and there are frequent epidemics through nutrition. Improvements in socioeconomic and sanitary circumstances have caused a shift in the disease’s prevalence worldwide. Younger children are usually asymptomatic, but as they become older, the infection symptoms begin to appear. Symptoms range from slight inflammation and jaundice to acute liver failure in older individuals. While an acute infection may be self-limiting, unrecognized persistent infections, and the misapplication of therapeutic methods based on clinical guidelines are linked to a higher incidence of cirrhosis, hepatocellular carcinoma, and mortality. Fortunately, most patients recover within two months of infection, though 10–15% of patients will relapse within the first six months. A virus seldom leads to persistent infection or liver damage. The mainstay of therapy is based on supportive care. All children from 12–23 months, as well as some susceptible populations, should receive routine vaccinations, according to the Centers for Disease Control and Prevention and the American Academy of Pediatrics. Laboratory diagnosis of HAV is based on antigen detection, checking liver enzyme levels, and antibody screening. Furthermore, polymerase chain reaction (PCR) technology has identified HAV in suspected nutrition sources; therefore, this technique is used for preventative measures and food-related laws.http://dx.doi.org/10.1155/2023/4263309
spellingShingle Omid Gholizadeh
Sama Akbarzadeh
Mohamad Ghazanfari Hashemi
Marjan Gholami
Parya Amini
Zahra Yekanipour
Raheleh Tabatabaie
Saman Yasamineh
Parastoo Hosseini
Vahdat Poortahmasebi
Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination
Canadian Journal of Infectious Diseases and Medical Microbiology
title Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination
title_full Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination
title_fullStr Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination
title_full_unstemmed Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination
title_short Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination
title_sort hepatitis a viral structure classification life cycle clinical symptoms diagnosis error and vaccination
url http://dx.doi.org/10.1155/2023/4263309
work_keys_str_mv AT omidgholizadeh hepatitisaviralstructureclassificationlifecycleclinicalsymptomsdiagnosiserrorandvaccination
AT samaakbarzadeh hepatitisaviralstructureclassificationlifecycleclinicalsymptomsdiagnosiserrorandvaccination
AT mohamadghazanfarihashemi hepatitisaviralstructureclassificationlifecycleclinicalsymptomsdiagnosiserrorandvaccination
AT marjangholami hepatitisaviralstructureclassificationlifecycleclinicalsymptomsdiagnosiserrorandvaccination
AT paryaamini hepatitisaviralstructureclassificationlifecycleclinicalsymptomsdiagnosiserrorandvaccination
AT zahrayekanipour hepatitisaviralstructureclassificationlifecycleclinicalsymptomsdiagnosiserrorandvaccination
AT rahelehtabatabaie hepatitisaviralstructureclassificationlifecycleclinicalsymptomsdiagnosiserrorandvaccination
AT samanyasamineh hepatitisaviralstructureclassificationlifecycleclinicalsymptomsdiagnosiserrorandvaccination
AT parastoohosseini hepatitisaviralstructureclassificationlifecycleclinicalsymptomsdiagnosiserrorandvaccination
AT vahdatpoortahmasebi hepatitisaviralstructureclassificationlifecycleclinicalsymptomsdiagnosiserrorandvaccination